sinc
human
infect
avian
mortal
pose
threat
public
health
review
describ
epidemiolog
transmiss
advantag
disadvantag
differ
influenza
vaccin
type
characterist
adenoviru
final
summar
advanc
adenovirusbas
system
mucos
vaccin
influenza
virus
notori
antigen
drift
shift
segment
negativesens
rna
genom
name
accord
two
surfac
protein
hemagglutinin
ha
neuraminidas
na
subtyp
respect
human
infect
influenza
viru
confin
subtyp
accord
record
howev
first
record
human
infect
avian
influenza
viru
occur
hong
kong
caus
viru
causal
reassort
hemagglutinin
ha
goos
seven
viral
gene
avian
influenza
virus
pathogenet
sequenc
analysi
reveal
belong
group
highli
pathogen
avian
influenza
virus
hpai
base
lethal
chicken
polybas
amino
acid
cleavag
site
ha
allow
ha
process
ubiquit
express
proteas
sinc
hpai
subtyp
caus
numer
outbreak
poultri
human
infect
case
mortal
http
wwwwhointinfluenzahumananimalinterfac
moreov
similar
season
influenza
virus
circul
human
hpai
subtyp
genet
highli
variabl
diversifi
multipl
phylogenet
clade
past
decad
henc
develop
vaccin
influenza
virus
challeng
asian
viru
kill
gees
detect
guangdong
provinc
china
hpai
viru
subtyp
caus
diseas
patient
six
death
hong
kong
exposur
live
poultri
week
onset
ill
associ
diseas
human
cull
poultri
hong
kong
end
first
wave
viru
continu
circul
among
avian
human
case
occur
two
hong
kong
resid
contract
diseas
one
die
second
wave
asian
occur
winter
eight
asian
countri
includ
china
cambodia
indonesia
japan
korea
lao
peopl
democrat
republ
thailand
vietnam
impact
particularli
sever
thailand
vietnam
widespread
diseas
report
poultri
well
human
case
fatal
may
virus
larg
confin
southeast
asia
infect
wild
bird
qinghai
lake
china
rapidli
spread
worldwid
even
though
sustain
humantohuman
transmiss
influenza
yet
describ
suggest
sever
household
cluster
addit
sever
studi
show
airborn
transmiss
achiev
adapt
experiment
test
therefor
remain
critic
public
health
concern
vaccin
effect
way
fight
influenza
pandem
howev
pose
particular
challeng
convent
inactiv
influenza
virusbas
vaccin
result
poor
immunogen
even
though
live
attenu
influenza
vaccin
laiv
attract
abil
mimic
natur
rout
infect
strong
system
mucos
immun
induc
laiv
licens
healthi
peopl
year
age
exclud
highrisk
human
group
furthermor
revers
virul
product
may
occur
reassort
circul
influenza
virus
may
happen
dnavaccin
made
rapidli
produc
larg
quantiti
howev
dna
vaccin
alon
poorli
immunogen
specif
instrument
need
immun
viruslik
particl
vlp
base
vaccin
antigen
mimic
nativ
virion
intact
biochem
activ
khurana
et
al
show
two
dose
vlp
mg
hados
induc
hemagglutin
inhibit
hai
seroconvers
rate
microneutr
mn
respect
human
indic
vlp
like
inactiv
vaccin
poorli
immunogen
even
though
subunit
vaccin
serv
conveni
method
gener
larg
amount
influenza
vaccin
potenti
pandem
properti
antigen
immunogen
inde
challeng
howev
adenovirusbas
vaccin
attract
base
selfadjuvant
rapid
product
eggindepend
method
administr
variou
rout
product
adenovirusbas
vaccin
relationship
adenoviru
immun
system
adenovirus
nonenvelop
icosahedr
doublestrand
dna
virus
target
gene
insert
adenoviru
genom
express
recombin
adenoviru
rad
infect
fig
base
delet
adenoviru
genom
sequenc
three
gener
rad
establish
first
gener
replac
gene
adenoviru
genom
gene
encod
antigen
interest
render
viru
replic
incompet
abl
produc
propag
hek
cell
allow
express
gene
interest
recombin
viru
upon
infect
order
increas
clone
capac
prolong
gene
express
reduc
toxic
associ
adenoviru
backbon
gene
express
second
gener
rad
develop
delet
gene
stabli
express
product
cell
third
gener
rad
helper
virusdepend
lack
nearli
viral
encod
sequenc
except
packag
signal
two
invert
termin
repeat
itr
enlarg
clone
capac
reduc
immunogen
gene
therapi
howev
first
gener
rad
wide
use
eas
manufactur
includ
product
purif
compar
two
gener
import
advantag
adenovirusbas
vaccin
adjuvant
stimul
innat
immun
respons
adenovirus
infect
variou
type
cell
epitheli
cell
macrophag
cell
dendrit
cell
shown
fig
upon
infect
adenovirus
activ
innat
immun
tolllik
receptor
tlr
depend
manner
well
tlrindepend
pathway
caus
upregul
type
interferon
ifn
inflammatori
cytokin
report
neutral
antibodi
type
ifn
could
block
innat
adapt
immun
respons
adenovir
vector
show
induct
type
ifn
play
import
role
adjuvant
adenovirus
endocytosi
adenoviru
genom
recogn
lead
activ
interferon
regulatori
factor
promot
induct
type
ifn
cytosol
adenoviru
genom
recogn
dna
sensor
cyclic
guanosin
monophosphateeadenosin
monophosph
cgamp
synthas
cga
anoth
unknown
dna
sensor
lead
activ
respect
ad
induct
type
ifn
promot
cellular
humor
immun
respons
sinc
reveal
low
immunogen
inactiv
vaccin
adenovirusbas
vaccin
wide
investig
tabl
gao
et
al
first
report
adenoviru
serotyp
vector
express
codonoptim
hemagglutinin
ha
gene
avietnam
influenza
viru
prepar
within
day
acquir
viru
sequenc
intramuscularli
vaccin
mice
fulli
protect
challeng
homolog
viru
addit
chicken
play
critic
role
mediat
transmit
human
complet
protect
lethal
challeng
singl
subcutan
immun
adenovirusbas
vaccin
later
report
singledos
ovo
vaccin
human
adenoviru
vector
encod
avian
influenza
viru
ha
fulli
protect
homolog
viru
also
provid
protect
demonstr
adenovirusbas
vaccin
could
administ
en
mass
use
avail
robot
ovo
injector
combin
differ
adenovirusbas
vaccin
also
studi
hoelscher
et
al
reveal
mice
vaccin
two
adenoviru
vaccin
encod
hemagglutinin
clade
clade
virus
protect
virus
minim
interfer
addit
adenovirusbas
multival
vaccin
encod
hemagglutinin
broadli
protect
significantli
high
level
ha
stalkspecif
antibodi
induc
follow
immun
multival
vaccin
scallan
et
al
report
vaccin
adenovirusbas
vaccin
oral
rout
protect
mice
ferret
upon
lethal
challeng
addit
crossclad
neutral
antibodi
induc
ferret
immun
peror
rout
also
report
dna
primeadenoviru
boost
vaccin
base
np
superior
trival
live
attenu
influenza
vaccin
protect
heterosubtyp
influenza
challeng
cite
studi
show
adenovirusbas
vaccin
effect
preclin
research
clinic
applic
adenovirusbas
vaccin
also
investig
phase
clinic
studi
vaccin
base
recombin
adenoviru
serotyp
show
oral
administ
vaccin
induc
signific
specif
cell
respons
one
boost
inactiv
vaccin
hai
mn
induc
vaccin
antrobu
et
al
report
replicationdefici
chimpanze
adenovirusvector
vaccin
express
conserv
influenza
antigen
np
safe
immunogen
human
even
though
adenovirusbas
vaccin
induc
system
immun
human
popul
preexist
immun
human
adenoviru
believ
preexist
adenoviru
neutral
antibodi
vector
immun
may
neg
impact
immun
respons
vaccin
antigen
deliv
human
adenoviru
vector
naiv
mice
immun
human
adenoviru
vector
express
ha
boost
bovin
adenoviru
vector
express
ha
singh
et
al
report
humor
respons
significantli
higher
either
alon
howev
immun
nonhuman
adenoviru
induc
immun
nonhuman
adenoviru
fact
taken
consider
immun
pandey
et
al
report
preexist
immun
adenoviru
overcom
either
increas
vaccin
dose
use
altern
rout
fig
three
signal
pathway
ifna
b
product
induc
adenoviru
stimul
endosom
genom
adenoviru
recogn
lead
activ
ikkadepend
pathway
addit
genom
adenoviru
cytoplasm
recogn
cga
suggest
unknown
dna
sensor
lead
activ
respect
lead
product
ifna
b
vaccin
mice
howev
whether
approach
work
human
need
investig
mucos
immun
via
nasal
rout
could
induc
cellular
humor
immun
respons
gener
mucos
cytotox
lymphocyt
igg
also
siga
secretori
iga
effect
prevent
penetr
pathogen
insid
cell
dissemin
throughout
human
bodi
howev
mucou
membran
upper
respiratori
tract
exhibit
low
epithelium
permeabl
thu
free
antigen
protein
peptid
unabl
induc
strong
immun
respons
adenovirusbas
vaccin
inde
satisfactori
mount
mucos
immun
respons
high
transduct
effici
variou
cell
type
epitheli
cell
dendrit
cell
activ
innat
immun
respons
adenovirusbas
mucos
vaccin
achiev
promis
result
hoelscher
et
al
show
intranas
immun
adenoviru
serotyp
express
induc
humor
cellmedi
immun
especi
interferongammasecret
cell
respons
order
elicit
high
level
potent
durabl
humor
cellular
respons
lower
airway
song
et
al
demonstr
aerosol
recombin
adenoviru
encod
complet
protect
ferret
result
adenoviru
vaccinebas
influenza
conserv
protein
encourag
park
et
al
report
mucos
immun
induc
adenovirusbas
vaccin
includ
two
conserv
influenza
protein
confer
protect
lethal
avian
influenza
viru
challeng
importantli
singl
intranas
sublingu
immun
adenoviru
express
np
provid
protect
protect
protect
also
singledos
mucos
immun
adenoviru
vaccin
encod
np
provid
rapid
full
protect
virul
virus
result
suggest
adenovirusbas
vaccin
serv
platform
ha
influenza
conserv
protein
mucos
immun
adenovirusvector
nasal
vaccin
also
bypass
preexist
immun
adenoviru
weak
viral
vector
addit
intranas
immun
adenovirusvector
vaccin
use
nasal
spray
would
suitabl
mass
vaccin
simplic
practic
howev
clinic
data
mucos
adenoviru
vaccin
human
yet
avail
sinc
human
infect
avian
influenza
viru
also
report
howev
continu
play
major
role
human
infect
avian
influenza
virus
high
mortal
rate
addit
given
widespread
presenc
among
avian
potenti
humantohuman
transmiss
ignor
vaccin
effect
way
prevent
potenti
pandem
avian
origin
high
mortal
rate
poor
immunogen
vaccin
base
tradit
method
use
season
influenza
unsatisfactori
therefor
new
vaccin
method
need
compens
weak
inactiv
vaccin
adenovirusbas
vaccin
attract
altern
sinc
serv
adjuv
activ
innat
immun
ii
eggindepend
iii
administ
variou
rout
especi
nasal
rout
endow
vaccin
strong
mucos
immun
conveni
applic
mass
vaccin
therefor
adenovirusbas
vaccin
especi
mucos
vaccin
may
effect
weapon
new
outbreak
howev
problem
preexist
immun
human
adenoviru
question
whether
immun
nonhuman
adenoviru
immun
nonhuman
adenoviru
human
imped
immun
taken
account
strategi
develop
previous
report
recombin
adenoassoci
viru
aav
encod
receptor
bind
domain
sarscov
spike
protein
induc
sarscovspecif
igg
antibodi
neutral
activ
studi
suggest
activ
immun
system
transgen
product
follow
aavmedi
gene
transfer
might
easier
control
follow
adenovirusmedi
gene
transfer
indic
aavbas
vaccin
lead
mild
immun
respons
therefor
combin
adenoviru
aav
vaccin
may
result
synergi
achiev
optim
immun
respons
adenovirusbas
vaccin
may
also
appli
new
emerg
virus
merscov
like
avian
origin
indic
eggindepend
vaccin
develop
addit
caus
seriou
infect
older
peopl
respond
less
effect
vaccin
thu
immun
adenovirusbas
may
efficaci
person
age
adenovirusbas
mer
vaccin
especi
rbd
region
may
effect
importantli
administ
intramuscular
intranas
immun
conclus
adenovirusbas
vaccin
promis
new
emerg
reemerg
virus
collabor
program
nation
grand
program
key
infecti
diseas
control
funder
role
design
implement
interpret
public
studi
